---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-023518"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2023-02-21T23:59:59+00:00"
generated_at: "2026-06-19T06:54:44.612528+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TELA Bio launches two larger OviTex LPR configurations for large abdominal hernia repair

## Summary
- New 15x20 cm and 15x25 cm ellipse sizes for ventral and incisional hernias.
- Designed for robotic and laparoscopic ports; low profile facilitates minimally invasive placement.
- In prior quarter, 40% of OviTex cases were robotic and 20% laparoscopic.
- OviTex LPR initially commercialized in 2018; new sizes expand product portfolio.

## SEC filing metadata
- accession: 0001104659-23-023518
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2023-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465923023518/0001104659-23-023518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465923023518/tm237356d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-023518
- JSON: https://secwatch.observer/filing/0001104659-23-023518.json
- Plain text: https://secwatch.observer/filing/0001104659-23-023518.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.